This was partly offset by a 1% rise in the company’s revenue from $46 billion to $47 billion over the same period; and a 4.1% ...

If it does prove to be the end of emraclidine for schizophrenia, that looks set to benefit Bristol-Myers Squibb, which ended ...

Analyst Gil Blum from Needham maintained a Buy rating on Recursion Pharmaceuticals (RXRX – Research Report) and keeping the price target ...

Analyst Ritu Baral of TD Cowen maintained a Buy rating on Avidity Biosciences (RNA – Research Report), retaining the price target of ...

Q3 2024 Earnings Call Transcript November 6, 2024 Evotec SE misses on earnings expectations. Reported EPS is $-0.12 EPS, ...

Hinen Australia offers Chrismas Promotion- Buy First Hinen System and Get a FREE 1800W Power ... Multiple Safety Protections: ...

Analog Devices (ADI) faces challenges with diverse product portfolios & missed out on high-growth markets like EVs. Read more ...

Bristol-Myers Squibb has said it will buy biotech MyoKardia in a $13.1 billion ... The all-cash deal is mainly about MyoKardia’s mavacamten drug that BMS thinks could be a first-in-class ...

Irish goods exports to the US last year were valued at €54 billion, accounting for close to one third of the State’s total goods exports. They also accounted for one-eighth of the EU’s total exports ...

Harbor Freight has revealed a large lineup of new products at SEMA 2024, including new power tools, power stations, and a ...

Neuland Labs share price surged after AbbVie’s emraclidine trial setback shifted focus to KarXT. As the exclusive Xanomaline ...

Independent specialist insurance broker BMS Group has launched BMS Bacchus, a stock throughput solution designed to protect ...